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It is widely accepted that glioblastoma (GBM) develops from cancer stem cells 
(CSCs), a subset of stem-like cells displaying high resistance to treatment. In fact, 
despite aggressive therapy, 90% of patients relapse within 2 cm from tumor edge. 
Our recent findings showed the existence of a CSC type, residing in GBM peritu-
mor tissue (PCSCs), that bears distinct characteristics from CSCs of the tumor mass 
(GCSCs). It should be considered the possibility that, after surgical resection, PCSCs 
might represent a reservoir of cells able to recapitulate the tumor. In this setting, char-
acterization of PCSCs appears to be crucial in order to identify novel effective thera-
peutic targets. Thus, our aim was to investigate GCSCs and PCSCs role in angiogene-
sis, a key event in both GBM and peritumor tissue, whose vasculature shows features 
similar to those found in the tumor mass. 
In particular, we analyzed, by immunocytochemistry (ICC), Western blotting or 
real-time PCR, the expression of molecules involved in hypoxia and angiogenesis, 
such as HIF1α, HIF2α, and VEGF along with its receptors (VEGFR1, VEGFR2). ICC 
has highlighted the presence and the specific localization of these molecules in both 
GCSCs and PCSCs. The two cell populations showed comparable levels of VEGF. 
The transcript of VEGFR1 was in general expressed at higher levels in GCSCs than 
in PCSCs, while VEGFR2 mRNA and protein did not show a unique trend of expres-
sion. 
The expression of VEGF and its receptors in both GCSCs and PCSCs suggests 
that, besides well-known paracrine loops, autocrine signalings are also involved in 
tumor angiogenesis. Moreover, the expression of angiogenesis markers in PCSCs sug-
gests these cells to have a direct role in peritumor tissue new vessel formation. In this 
regard, PCSCs should be considered a promising therapeutic target to counteract the 
angiogenesis-supported tumor progression.
